Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Why Is Cassava Sciences' Stock So Volatile?
08:00pm, Thursday, 12'th Aug 2021
The stock is up 1,700% year to date.
Cassava Sciences vs. Biogen
05:32pm, Thursday, 12'th Aug 2021
Who will emerge victorious in the race to help Alzheimer's patients?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
10:04pm, Wednesday, 11'th Aug 2021
NEW YORK, Aug. 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Such investors are adv
Here's What Investors Should Know About Cassava's Alzheimer's Drug Candidate
03:15pm, Wednesday, 11'th Aug 2021
Cassava believes that a mutating protein, Filamin A, is a major culprit behind Alzheimer's disease. The company's drug, simufilam, aims to fix this mutation and restore its proper form and function.
Bring a Neck Brace When Trading Cassava Sciences
01:36pm, Wednesday, 11'th Aug 2021
Cassava is still pre-revenue but SAVA stock has a flock of strong fans. They bought the dip with gumption, which suggests long-term success.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
07:19pm, Monday, 09'th Aug 2021
New York, New York--(Newsfile Corp. - August 9, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Such inves
Why Shares of Cassava Sciences Fell 18.6% in July
05:02pm, Monday, 09'th Aug 2021
The stock lost $75 a share in two days at the end of the month.
What to Do After Cassava Sciences Dropped Off a Cliff
06:00am, Monday, 09'th Aug 2021
Cassava Sciences posted positive clinical data but triggered a sell on the news event, as SAVA stock short sellers welcomed the drop. The post What to Do After Cassava Sciences Dropped Off a Cliff app
Cassava Sciences May Be Revolutionary in the Alzheimer's Fight
02:39pm, Thursday, 05'th Aug 2021
SAVA stock is truly worth paying attention to from here forward as data suggests Cassava Sciences may have solved a big mystery. The post Cassava Sciences May Be Revolutionary in the Alzheimer's Fight
Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
12:36pm, Thursday, 05'th Aug 2021
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
08:03pm, Tuesday, 03'rd Aug 2021
NEW YORK, Aug. 3, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Such investors are advis
Detours In The Golden Age Of Alzheimer's Drug Stock Investments
02:58pm, Tuesday, 03'rd Aug 2021
Biogen's Aduhelm performed no better than placebo in non-ApoE4 carriers and only slightly slowed down the progression of Alzheimer's disease in ApoE4 carriers.
SAVA Stock Price Increases Over 17% Intraday: Why It Happened
01:15pm, Tuesday, 03'rd Aug 2021
The stock price of Cassava Sciences Inc (NASDAQ: SAVA) increased by over 17% during intraday trading. This is why it happened.
Cassava Sciences Stock Has Been Hammered For No Good Reason and Is Likely To Rebound
12:46pm, Tuesday, 03'rd Aug 2021
Cassava Sciences stock has been hammered for no good reason and is likely to rebound. AVA stock is still worth over $900 especially given the recent positive 9-month results of its Alzheimer's drug Si
Why Former NYSE Trader David Green Bought NVIDIA, Tesla, and Cassava Sciences On Tuesday
11:42am, Tuesday, 03'rd Aug 2021
Veteran trader David Green was back live trading on Benzinga Tuesday morning, and the long-time trader made some moves. Green pointed out the strength of NVIDIA Corporation (NASDAQ:NVDA) Tuesday mor
